A therosclerosis is a progressive, chronic inflammatory disease resulting in plaque formation in large arteries 1,2 that can lead to heart attack, stroke, and death. Targeting the immune cells that participate in atherogenesis is a promising novel approach for atherosclerosis treatment and prevention. 3 Much is known about the recruitment of macrophages and T cells to the vessel wall and their role in plaque progression 4 ; however, B cells in atherosclerosis are incompletely understood. As early as the 1960s, studies have identified B cells, plasma cells, and immunoglobulins in association with atherosclerotic plaques of mice and humans. [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] More recent studies in mice identified B-cell-containing aortic tertiary lymphoid organs (ATLO) in the adventitia adjacent to atherosclerotic plaques, raising the possibility that adventitial B cells may regulate a local immune response within the vessel wall. 5, 6, 14 In addition, although ATLOs are not present in the normal/noninflamed aorta before Western feeding, 5 a significant population of leukocytes, including B cells, are present in the aortic adventitia of normal vessels. 14 Global B-cell deficiency established before Western diet feeding 15, 16 results in increased atherosclerosis in mice, suggesting that B cells function in early atheroprotection. Yet, the molecular mechanisms that regulate homeostatic trafficking of B cells to the aorta and their impact on the development of atherosclerosis are unknown.
Inhibitor of differentiation-3 (Id3), a member of the helixloop-helix (HLH) family of transcription factors, is a domi-nant negative inhibitor of bHLH protein-DNA binding and gene expression in B cells. 17 The Id3 Ϫ/Ϫ mouse has normal numbers and maturity of B cells but develops a Sjögren-like syndrome with lachrymal and salivary glands lymphocytic infiltrates, 18, 19 raising the interesting possibility that Id3 may regulate B-cell homing to sites of disease. That hyperlipemia increased Id3 expression in vitro and in the vessel wall in a porcine model suggested a link between Id3 and atherosclerosis. 20 This link was recently confirmed by studies demonstrating that aged and Western diet-fed Apoe Ϫ/Ϫ mice null for
Id3 had significantly increased atherosclerosis compared with Apoe Ϫ/Ϫ mice wild-type for Id3. 21 Moreover, Id3 may be involved in atheroprotection in humans as the human ID3 gene contains a single nucleotide polymorphism (SNP) that alters Id3 protein function and is associated with increased carotid intima-media thickness in humans. 21 The present study demonstrates a new function for Id3, as a critical regulator of B-cell aortic trafficking and B-cellmediated atheroprotection and identifies CCR6 as an Id3 target gene mediating these effects. In addition, we provide the first evidence that B cells home to regions prone to and with existing atherosclerosis leading to reduced macrophage accumulation and attenuation of lesion progression.
Methods
Detailed experimental procedures and associated references are in the Online Supplemental Material available at http://circres.ahajournals.org. All procedures using animals were carried out according to protocols approved by the Animal Care and Use Committee at the University of Virginia. For B-cell adoptive transfer studies, spleens were harvested from 10-to 12-week-old mice and B cells were isolated by negative selection using MACS anti-CD43 microbeads or a combination of MACS anti-CD43, anti-CD4, and anti-CD11b microbeads (Miltenyi Biotec). Serum cholesterol levels were determined using an Archtect 8000 series analyzer. Antibody titers were determined as detailed in the Online Supplemental Material.
Analysis of Atherosclerosis
After euthanizing the mice, the aorta was harvested from the heart to the iliac bifurcation. Both en face Sudan IV staining of the aorta and cross-sectional analysis of the root was used in this study to quantify atherosclerosis. Fluorescent imaging at the UVA Advanced Microscopy Core enabled identification of CFDA-SE-labeled B cells within the aorta. Immunohistochemical analysis of atherosclerosis was achieved through staining for MCP-1 (Santa Cruz Biotechnology Inc) and macrophage content was determined with Mac-2 staining (Cedarlane Laboratories). These protocols are detailed in the Online Supplemental Material. 
Bone Marrow Transplantation

Flow Cytometry
Lymph nodes, spleens, blood, and aortas, including the adventitia, were harvested under a dissection microscope and processed for flow cytometry as previously described 14 and detailed in the Online Supplemental Material.
Ex Vivo Imaging of Radiolabeled B Cells
B cells were radiolabeled by incubation in indium-111 oxine solution. After adoptive transfer of radiolabeled B cells, aortas were harvested and exposed to a high-sensitivity, medium-resolution phosphor imaging screen (PerkinElmer) overnight. The phosphor imaging screen was scanned using a PerkinElmer Cyclone Plus Phosphor Imaging System. This protocol is detailed in the Online Supplemental Material.
Optical Imaging of Aortic B Cells
Ex vivo fluorescence-mediated tomography (FMT) quantitative imaging (FMT 2500, VisEn Medical) was performed after incubation of aortas with Cy5.5-labeled anti-B220 antibodies (eBiosciences and Rockland Immunochemicals). This protocol is detailed in the Online Supplemental Material.
Real-Time PCR
Total cellular RNA was collected from B cells using an RNeasy kit (Qiagen) as per the manufacturer's instructions, cDNA was then synthesized using an iScript cDNA synthesis kit (BioRad), and real-time PCR reaction using a Bio-Rad iCycler and iQ SYBR Green Supermix (BioRad) was performed as detailed in the Online Supplemental Material.
Cellular Migration Studies
Splenic B cells were purified from Id3 ϩ/ϩ Apoe Ϫ/Ϫ and Id3
Apoe Ϫ/Ϫ mice and placed in the upper chamber of 5-m pore size transwells containing either 1000 ng/mL of CXCL13 or 500 ng/mL of CCL20 in the bottom of the transwell. After incubating for 6 hours, the number of cells that had migrated through the transwell was counted, using a flow cytometer as detailed in the Online Supplemental Material.
Statistical Analysis
A probability value Ͻ0.05 was considered statistically significant. All statistical analyses were performed using NCSS 2001 (Number Crunching Statistical Software, Kaysville, UT) and GraphPad Prism5 (La Jolla, CA). Statistical analysis is detailed in the Online Supplemental Material. (Figure 2A ), T cells ( Figure 2B ), and dendritic cells ( Figure 2C ). The number of macrophages was higher in the aortas of Id3 Ϫ/Ϫ Apoe Ϫ/Ϫ mice ( Figure 2D ). In contrast, the number of B cells in the aorta was significantly lower in Id3 Ϫ/Ϫ Apoe Ϫ/Ϫ mice ( Figure 2E and 2F). This finding cannot be explained by a global reduction in the number of B cells in the Id3 Ϫ/Ϫ Apoe Ϫ/Ϫ mouse, as consistent with previous findings in Id3 Ϫ/Ϫ mice, 18 the number of B cells in the spleen, peri-aortic lymph nodes, and whole blood (Table 1) .
Results
Id3 Is Necessary for Early Atheroprotection
Optical Imaging Confirms Fewer B Cells in Aorta of Id3
؊/؊ Apoe ؊/؊ Mice
and Reveals That the B Cells Present Predominantly Localize to Atheroprone Regions of the Aorta
Optical imaging using a Cy5.5-labeled anti-B220 antibody provided a second method to demonstrate B cells in the aorta
mice. As a control, MT mice, which lack peripheral B cells due to deletion of genomic DNA sequences that encode the transmembrane domain of the B-cell receptor heavy chain, 22 were bred to Apoe
Ϫ/Ϫ aortas were found to have a minimal amount of background signal, which probably represents the nonspecific retention of the Cy5.5-labeled anti-B220 antibody. Although a significant increase in fluorescence over background was observed in both Id3 ϩ/ϩ Apoe Ϫ/Ϫ and Id3 Figure 2G ), consistent with our previous flow cytometric data, the increase in fluorescence over controls in the aortas of Id3 Ϫ/Ϫ Apoe Ϫ/Ϫ mice was significantly lower than that in the aortas of Id3 ϩ/ϩ Apoe Ϫ/Ϫ mice (15% versus 42%; PϽ0.0006) ( Figure 2G and 2H). Notably, peak fluorescence was greatest within the aortic arch and the abdominal aorta ( Figure 2G ), regions that are particularly prone to the development of atherosclerosis in this animal model. 23 mice were adoptively transferred to MT Apoe Ϫ/Ϫ mice. Control animals received an equal volume of vehicle. Six, 24, or 72 hours after the transfer of purified B cells, the aorta, spleen, lymph nodes, and whole blood were harvested ( Figure 3A ) and analyzed by flow cytometry as described above. Apoe Ϫ/Ϫ B cells wild-type for Id3 appear in the aorta 6 hours after tail vein injection and continue to accumulate in the aorta up to 72 hours later. In contrast, no appreciable numbers of Id3 Ϫ/Ϫ Apoe Ϫ/Ϫ B cells appear in the aorta at any of the time points tested ( Figure 3B) . Analysis of the spleens, lymph nodes, and whole blood of the same animals revealed that B-cell reconstitution of these compartments was similar between the two genotypes at each time point, providing evidence that reduced aortic B-cell number was not due to a reduction in the total B-cell pool (Table 2) .
To confirm Id3-dependent trafficking of B cells to the aorta, imaging of radiolabeled B cells injected into MT Figure 3C and 3D). Consistent with optical imaging data ( Figure 2G ), radiolabeled B cells traffic to regions of the aorta that are prone to atherosclerosis ( Figure 3C and 3E) . To determine the layer of the vessel wall to which B cells traffic in these experiments, splenic B cells were purified from Id3 ϩ/ϩ Apoe Ϫ/Ϫ mice, incubated with CFDA-SE, and adoptively transferred to MT Apoe Ϫ/Ϫ mice. Seventy-two hours after transfer, aortas were harvested from mice, sectioned and analyzed for the presence of these labeled B cells. Although the media and scattered adventitial cells revealed autofluorescence, CFDA-SE labeled B cells were only detected within the adventitia ( Figure 3F) . B cells in the spleen served as a positive control and spleen from mice receiving vehicle injection served as negative control. 
Ϫ/Ϫ Apoe Ϫ/Ϫ mice, there were Ͻ200 B cells in the aorta regardless of the number of B cells injected (data not shown and Figure 3B ). There were no differences in the numbers of peripheral B cells (Table 3 ). These data demonstrate that B cell delivery before Western diet feeding protects MT Apoe Ϫ/Ϫ mice from diet-induced atherosclerosis and that Id3 is essential for this B-cellmediated attenuation of atherosclerosis.
CCR6 Is a Novel Id3 Target Regulating B-Cell Homing to the Aorta and Atheroprotection
To determine the chemokine receptors on B cells that may be regulating homing to the aorta in an Id3-dependent manner, recipients by tail vein injection. Control animals received an equal volume of PBS vehicle. Animals were allowed to recover for 72 hours, then fed a Western diet for 16 weeks. Aortas were harvested and analyzed by en face as described in Figure  1 . B, Representative photos of aortic Sudan IV staining. C, Quantification of aortic lesion size. Each point represents a single animal. *PϽ0.05, **PϽ0.002, ***PϽ0.001, ****PϽ0.005. Figure 5A ). No change was noted in the levels of CXCR5, CXCR6, and L-selectin, which have previously been demonstrated to play a role in T-cell homing to the aorta. 14, 24 Differences in surface expression of CCR6 protein was confirmed by flow cytometry ( Figure 5B ) and impaired migration of Id3 Ϫ/Ϫ Apoe Ϫ/Ϫ B cells in response to the cognate ligand for CCR6 (CCL20) was demonstrated using transwell assays ( Figure 5C ). Id3 regulates target gene expression through dimerization with E2A gene products, such as E12, antagonizing E12 DNA binding and transcription regulatory effects. Transient cotransfection studies in BJAB cells (a human B-cell lymphoma line), demonstrated that E12 inhibits CCR6 promoter activation, an effect antagonized by cotransfection with an expression plasmid encoding Id3 ( Figure 5D ). Flow cytometry of aorta from C57BL/6 (B6) and CCR6 Ϫ/Ϫ mice revealed fewer aortic B cells in CCR6 Ϫ/Ϫ mice than those of age-matched littermate B6 control mice ( Figure 5E Figure 5I ). These data identify CCR6 as an Id3 target involved in the aortic "address" for B-cell homing and B-cell-mediated atheroprotection.
B Cells Traffic to Regions of the Aorta With Existing Atherosclerosis
Optical and phosphor imaging demonstrated that B cells traffic to regions of the aorta known to be prone to atherosclerosis (Figures 2 and 3) . To directly determine if B cells traffic to regions of atherosclerosis, MT Apoe Ϫ/Ϫ mice were fed 8 weeks of Western diet to develop atherosclerosis. Animals were then injected with 2ϫ10 7 radiolabeled Apoe Ϫ/Ϫ B cells or vehicle control. En face staining with Sudan IV demonstrated lipid deposition predominantly in the arch and abdominal aorta. Ex vivo phosphor imaging of aortas revealed the highest signal intensity in the regions of the aorta positive for Sudan IV staining ( Figure 6A) . Injection of an equal number of radiolabeled Id3 Ϫ/Ϫ Apoe Ϫ/Ϫ B cells served as a control as we previously demonstrated an aortic homing defect in B cells null for Id3 (Figure 6A and B) .
Delivery of Id3
؉ 6 Apoe Ϫ/Ϫ B cells (nϭ9) or vehicle control (nϭ13). Injected animals received an additional 8 weeks of Western diet and were then assessed by en face staining of the descending aorta and cross-sectional analysis of the aortic arch. Movat staining of cross sections confirm that en face lipid staining was accompanied by the histomorphologic components of atherosclerotic plaque (necrotic core and cellular infiltration). Consistent with whole aorta en face findings (Figures 4 and 6) , there was significant atherosclerosis in the abdominal aorta by en face staining and in the arch by cross-sectional analysis in the vehicletreated group. In contrast, adoptive transfer of B cells from Apoe Ϫ/Ϫ mice significantly attenuated the progression of atherosclerosis when compared with vehicle recipients as measured by en face (4.9Ϯ0.7% versus 9.7Ϯ1.3% respectively, Pϭ0.011) ( Figure 6C ) and cross-sectional analysis (35.6Ϯ3.2% versus 45.3Ϯ3.1%, Pϭ0.046) (Figure 6D and E). Serum collected at the time of aorta harvest was analyzed for lipids. There were no significant differences in plasma cholesterol, triglycerides, or OxPL/apoB levels between the groups (data not shown).
B Cells Attenuate Aortic Macrophage Content
The mechanisms whereby aortic B cells attenuate plaque development are unknown. As Id3 Ϫ/Ϫ mice have increased total IgM in serum, 25 we investigated the serum levels of antibodies known to be correlated with atherosclerosis in Id3 ϩ/ϩ Apoe Ϫ/Ϫ and Id3 Ϫ/Ϫ Apoe Ϫ/Ϫ chow-fed mice. Paradoxically, IgM MDA-LDL and IgM Cu-OxLDL, which are associated with lower levels of atherosclerosis, 26 were found to be increased in Id3 Ϫ/Ϫ Apoe Ϫ/Ϫ mice compared with Id3 ϩ/ϩ Apoe Ϫ/Ϫ mice. Levels of IgG MDA-LDL and IgG Cu-OxLDL were not significantly different between groups (Online Table I ). Macrophages are present in the aorta before Western diet feeding 14 ( Figure 2D ) and infiltrate the vessel 
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wall early in the disease process. 3 To determine if B-cell delivery to MT Apoe Ϫ/Ϫ mice alters plaque macrophage content, immunohistochemical staining of plaques from vehicle and B-cell injected MT Apoe Ϫ/Ϫ mice was performed. Compared with control, adoptive transfer of B cells resulted in a significant reduction in Mac2 ( Figure 6F and 6G, 0.34Ϯ0.02 versus 0.42Ϯ0.02, respectively, Pϭ0.024), and MCP-1 staining ( Figure 6F and 6H, 0.074Ϯ0.009 versus 0.121Ϯ0.012, Pϭ0.007). Flow cytometry analysis of MT Apoe Ϫ/Ϫ mice injected with Apoe Ϫ/Ϫ B cells to before Western diet feeding also revealed a significant decrease in aortic macrophage number ( Figure 6I and 6J) .
Discussion
The present study clearly demonstrates that B cells can attenuate atherosclerosis and provides the first evidence linking resident aortic B cells with this atheroprotection. Previous studies using transplantation of bone marrow from B-cell-deficient MT to Ldlr Ϫ/Ϫ mice 16 or splenectomy of Apoe Ϫ/Ϫ mice 15 had suggested an atheroprotective role for B cells. However, more recent studies using a strategy of reducing circulating B cells with CD20 monoclonal antibody treatment resulted in attenuation of atherosclerosis, 27, 28 suggesting that the impact of B cells on atherosclerosis may be subset and context-dependent. Indeed, recent studies have addressed the subset question and provide evidence that B2 cells promote 27, 28 whereas B1a cells attenuate Western dietinduced atherosclerosis. 29 Results herein, address the question of context, providing the first evidence that mice with B cells resident in the aorta at baseline have less atherosclerosis in response to Western diet feeding compared with those with few aortic B cells. Id3 Ϫ/Ϫ Apoe Ϫ/Ϫ mice, which had preserved numbers of circulating B cells but lacked sufficient aortic B cells ( Figure 2F and 2G) , developed significantly more atherosclerosis than Id3 ϩ/ϩ Apoe Ϫ/Ϫ mice (Figure 1 ). (Table 2 ), but aortic reconstitution (Figure 3b ) and attenuation of Western diet-induced atherosclerosis ( Figure 4C ) were significantly impaired. That the adoptively transferred B cells come from a hyperlipemic mouse on an atherogenic background (Apoe Ϫ/Ϫ ) appears to be important as neither 5 28 Further support for aortic B-cell-mediated atheroprotection is provided by the finding that B cells from Apoe Ϫ/Ϫ mice null for CCR6 but wild-type for Id3 also had reduced aortic B-cell homing and B-cell-mediated atheroprotection ( Figure 5 ). Taken together, results provide evidence for a model of atheroprotection whereby resident aortic adventitial B cells serve as early responders to atherogenic signals in the vessel wall to limit atherosclerosis.
Chemokine receptors provide the "address" for leukocyte homing to tissues 31 and results of the present study provide the first evidence that CCR6 is important for B-cell trafficking to the aorta and attenuation of Western diet-induced atherosclerosis. Yet, mice globally deficient in CCR6 have attenuated atherosclerosis. 32 CCR6 is expressed on various cell types involved in atherosclerosis, 33 and mice globally deficient in CCR6 have reduced circulating monocytes due to an reduced ability of these cells to leave the bone marrow, 32 providing evidence that CCR6 may have opposing effects on atherosclerosis development dependent on the cell type in which it is modulated. CCR6 has been identified as an important component of B-cell trafficking to form isolated lymphoid follicle formation in the gut in inflammatory states 34 suggesting that CCR6 may be a common chemokine receptor mediating B-cell homing to tissue sites to modulate local inflammation. 5, 6 Results of the present study demonstrate that CCR6 is an Id3 target and that CCR6 regulates B-cell homing to the aorta and B-cell-mediated atheroprotection. Of note, the magnitude of the aortic homing defect in B cells from Id3 Ϫ/Ϫ Apoe Ϫ/Ϫ mice is greater than that seen in CCR6 Ϫ/Ϫ mice, suggesting that additional chemokine receptors may participate with CCR6 in the aortic "address." Previous reports have identified CXCR6 and L-selectin as important regulators of T cell homing to the aorta, 14, 24 however our results suggest that the "address" for B-cell homing to the aorta is independent of these factors. Gräbner et al have implicated vessel wall expression of CXCL13 and CCL21 in the formation of B-cell-rich ATLOs adjacent to advanced plaques in aged Apoe Ϫ/Ϫ mice. 5 Yet, in our studies of younger mice, B cells from Id3 ϩ/ϩ Apoe Ϫ/Ϫ and Id3
Apoe Ϫ/Ϫ mice had similar expression of CXCR5 (receptor for CXCL13) and CCR7 (receptor for CCL21) and transmigration in response to CXCL13 compared with controls ( Figure  5 and data not shown), suggesting that unique chemokine signals may recruit B cells to the vessel wall before lesion development and in the early stages of atherosclerosis as compared with advanced lesions. It is also possible that Id3 may regulate other downstream target genes not involved in B-cell homing but involved in B-cell-mediated atheroprotection.
Id3 dimerizes with E-proteins such as the E2A gene products, E12 and E47, which have critical functions in B cells. 35 As such, B cells from Id3 null mice may have other functional defects that promote atherogenesis. B cells produce antibodies and cytokine that modulate innate and adaptive immune responses. Evidence suggests that antibodies directed at oxidized phospholipid epitopes, such as OxLDL and MDA-LDL, may modulate atherosclerosis. In particular, IgM specific for OxLDL and MDA-LDL have been suggested to attenuate the development of atherosclerosis, 26,36 -39 whereas IgG specific for these epitopes may be atherogenic. 38, 40 Given that the major site of LDL oxidation is in the artery wall, it seems plausible that resident aortic B cells may be stimulated with vessel wall antigens to produce protective autoantibodies in the spleen or local tissue. We therefore explored circulating levels of several of these antibodies known to be associated with atherosclerosis. Paradoxically, serum levels of IgM to MDA-LDL and OxLDL were both increased in Id3 Ϫ/Ϫ Apoe Ϫ/Ϫ mice compared with control. Consistent with previous literature 18 examining antibody levels in young Id3 Ϫ/Ϫ mice, the loss of Id3 in Apoe Ϫ/Ϫ mice was also associated with an increase in total serum IgM levels. This raises the possibility that the increased IgM MDA-LDL and OxLDL observed in these mice may be secondary to a nonspecific global increase in all IgMs. Moreover, the increased, not decreased, levels of the putatively protective IgM MDA-LDL and OxLDL in the Id3 Ϫ/Ϫ Apoe Ϫ/Ϫ mice make it unlikely that production of these specific antibodies is the mechanism for the increased atherosclerosis.
B cells have long been known to reside in the adventitia of diseased arteries of mice and humans, [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] yet the specific location of these adventitial B cells in relation to atheroprone regions of the vascular tree has not been known. We demonstrate that B cells traffic to ( Figure 3D ) and reside ( Figure 2G ) in atheroprone regions of the aorta (the aortic arch and the descending abdominal aorta). Moreover, we demonstrate that B cells traffic to regions with existing lipid deposition ( Figure  6A ), reduce macrophage content within lesions ( Figure 6F , 6G, and 6H) and retard the progression of these early lesions ( Figure 6C ). Interestingly, our results suggest that B cells regulate macrophage content of the aorta in response to Western diet feeding and even before feeding. Although • Id3 is necessary for early atheroprotection.
• Loss of Id3 reduces B-cell CCR6 expression and deficiency of both ID3 and CCR6 reduces B-cell aortic homing and B-cell-mediated atheroprotection.
• B cells home to sites in the aorta prone to atherosclerosis and regions with early lipid deposition, reduce the macrophage content of the lesion, and attenuate atherosclerosis progression.
B cells have been shown to both aggravate and attenuate atherogenesis, suggesting that the effects of B cells may be subset-or context-dependent. Here, we provide evidence that the effects of B cell on atherosclerosis are context-dependent based on the following findings: (1) Apoe Ϫ/Ϫ mice with reduced number of aortic, but normal number of peripheral B cells have increased atherosclerosis. (2) B cells home to, and attenuate initiation and progression of atherosclerosis in, regions of the aorta prone to atherosclerosis and attenuate initiation and progression of atherosclerosis. Our results identify the helixloop-helix factor, ID3 as a critical regulator of B-cell aortic homing and B-cell-mediated atheroprotection and define CCR6 as one downstream target of ID3 that promotes aortic B-cell homing and B-cell-mediated atheroprotection. Taken together with previous findings of a functionally significant SNP in the human Id3 gene associated with carotid thickening in humans, these results suggest that strategies to enhance Id3 expression or function may provide immune protection against atherosclerosis.
